Article
Multiplexed single-tier immunoassay for improved Lyme disease diagnosis across all disease stages
2026-02-09
Abstract excerpt
<title>Abstract</title> <p>Lyme disease is the most common vector-borne infection in North America and Europe, yet current two-tier serologic testing shows poor sensitivity during early infection when antibiotic treatment is most effective. We developed and validated a single-tier multiplex immunoassay that combines ten Borrelia burgdorferi antigens with machine-learning classification to detect antibody response...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1b2148fa-6686-5ac0-b31c-68a65e6ec699
- DOI
- 10.21203/rs.3.rs-8502997/v1
